Member Info for nomlungu

writemyowncode,

Are you using Keras?

how many swapies live there

excellent theory!

Simon_Said

Thank you for your update

I am presuming you went to the event - if so, thank you for the update.

I had a quick read of the report - it reminded me of 2 things:

The new CFO starting in November. Applied Graphene Materials has not faired so well whilst he has been their CFO. This is just an observation - I have no knowledge why AGM's share price has dropped 80 percent over 3 years.

The need for further funding - even the Hardman Report acknowledges that around £7m will need to be raised. I am expecting it to be more but even at £14m this would only be a dilution of 15 percent at current market capitalisation.

On a much more positive note - even though Hardman are paid for their publicity 'research' by TRX, they will not have received actual figures. I am expecting the actual figures to be better and the share price to increase accordingly [and of course, then a placing at some unknown discount]. I have great faith and expectations in the science and TRX.

The only potential problems are Trump, Brexit and the US Attorney General's Religious Liberty Task Force. The Task Force could impact the uptake of any stem cell based products in rural Catholic Hospitals.

Nothing happening - the sp is down 40 percent this week.

fight night tonight - it appears that...

it is a conspiracy

fomo rules seem to be in play

Are there any persistent thoughts about adaptimmune's approach on this board? They release their accounts tomorrow

https://www.adaptimmune.com/technology/our-engineered-t-cell-therapies

Their Q2 update is due to be released at 8am eastern time [13h00 in the uk]

CHELSEA7,

SCIB1 - the 5 year survival rates are what interested me... SCIB2 targets the lung cancer antigen NY-ESO-1 - there is a lot of promise here for my speculative funds.

https://duckduckgo.com/?q=NY-ESO-1+abcam&t=hb&ia=web

The only way to invest in d-wave from the UK is through 180 Degree Capital Corp [NASDAQ: TURN] as far as I am aware. It is a fund like IP Group but you need to invest dollars not pounds.

Be wary of the effect the Tangerine Man may have and put little trust in what people post on bulletin boards.

RuckRover,

Quantum annealing is ideal for solving the travelling salesman problem. D-Wave has a 2000 qubit machine that has shown promise in various areas including protein shape research/identification. If you have any interest the links below may be of interest:

http://openmunich.eu/pdf/Solving_the_Travelling_Salesman_Problem_Using_Quantum_Computing.pdf

https://en.wikipedia.org/wiki/Quadratic_unconstrained_binary_optimization

https://www.dwavesys.com/press-releases/usc-viterbi-quantum-machine-shows-promise-biological-research

Wildforce,

I have bought some shares with a bit of my moonshot fund. I was planning on some Abcam shares at the same time but they have spiked 10 percent this week and I do not see a/the reason for the rise.

According to pumpedordumped there have been 196 trades so far today when there were only 641 trades in July (of which 227 were on Monday and Tuesday... If July had 32 days then over half of the trades for the month would have taken place this week.

Looks like a bit of FOMO is spreading and I am expecting the news flow to be positive over the next 6 months. I am expecting a nice Xmas present here.

http://pumpedordumped.com/data/searchcompany.php?search=RBD

I am trying to monetise quantum annealing

https://en.wikipedia.org/wiki/Quantum_annealing

https://www.darpa.mil/

inanaco,

thank you for your detailed post

CHELSEA7,

I do have some interest. The SCIB1 and SCIB2 trials have delivered positive results; Modi-1 is interesting science.

I do ask questions here as this share seems to full-fill the criteria for potential investments for a potion of my moonshot funds and most posters have some scientific knowledge.

The cash burn question - to me it is perfectly rational to consider the cash flow situation of all biotech companies - some raise a huge amount to fund years of research that never get anywhere, some raise cash as they progress. For what it is worth, I do consider the increasing placing price, despite the dilution, to be a positive.

I do have 2 general concerns against AIM biotech shares that I am currently invested in - the Tangerine Man and Brexit. The US attorney general today announced a new initiative called the 'Religious Liberty Task Force'. This potentially causes untold damage to my investments that rely on human and porcine derived tissue / stem cells. Having the EMA leave London increases compliance costs and complexity - I hate watching white noise injected into my investments.

https://www.thedailybeast.com/jeff-sessions-religious-liberty-task-force-declares-holy-war-on-lgbt-people?ref=home

They are looking for Junior DevOps Engineers (Halcyon IoT Solutions Team); Software Engineers (Senior & Junior) [Immediate Start preferred] and Field Delivery Engineers (Electrical) [Immediate Start and share options]. The link is below:

http://www.photonstartechnology.com/aboutus/careers/